Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
4-(3-BENZOYLAMINOPHENYL)-6,7-DIMETHOXY-2- METHYLAMINOQUINAZOLINE DERIVATIVE
Document Type and Number:
WIPO Patent Application WO/2007/097317
Kind Code:
A1
Abstract:
A compound represented by the formula (I) below, a salt thereof or a hydrate of any of them is capable of effectively suppressing itch of atopic diseases and the like. (I) [In the formula, R represents a hydroxyl group, a C1-6 alkoxy group which may be substituted by a C1-6 alkoxy group, or an amino group which may be substituted by a C1-6 alkyl group.]

Inventors:
MIYAZAKI KAZUKI (JP)
KUSANO KAZUTOMI (JP)
TAKASE YASUTAKA (JP)
ASANO OSAMU (JP)
SHIRATO MANABU (JP)
WAKITA HISASHI (JP)
ISHII NAOTO (JP)
SAEKI TAKAO (JP)
Application Number:
PCT/JP2007/053066
Publication Date:
August 30, 2007
Filing Date:
February 20, 2007
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
EISAI R&D MAN CO LTD (JP)
MIYAZAKI KAZUKI (JP)
KUSANO KAZUTOMI (JP)
TAKASE YASUTAKA (JP)
ASANO OSAMU (JP)
SHIRATO MANABU (JP)
WAKITA HISASHI (JP)
ISHII NAOTO (JP)
SAEKI TAKAO (JP)
International Classes:
C07D239/84; A61K31/517; A61P17/00; A61P17/04; A61P37/08
Domestic Patent References:
WO1999037622A11999-07-29
WO2005082865A12005-09-09
Foreign References:
JP2001520196A2001-10-30
Other References:
HANIFIN J.M. ET AL.: "Type 4 Phosphodiesterase Inhibitors Have Clinical and In Vitro Anti-inflammatory Effects in Atopic Dermatitis", THE JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 107, no. 1, July 1996 (1996-07-01), pages 51 - 56, XP000915565
SCHMIDT B.M.W. ET AL.: "The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis", THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 108, no. 4, October 2001 (2001-10-01), pages 530 - 536, XP008016318
See also references of EP 1992622A4
Attorney, Agent or Firm:
HASEGAWA, Yoshiki et al. (Ginza First Bldg. 10-6, Ginza 1-chom, Chuo-ku Tokyo 61, JP)
Download PDF: